BS in Bioprocessing of New Medicines (Business & Management)

The domestic student fees for the BS in Bioprocessing of New Medicines (Business & Management) at University College London are $12,065, while international students are required to pay $39,800.

The next available intake for the BS in Bioprocessing of New Medicines (Business & Management) at University College London is in September 2025.

To apply for the BS in Bioprocessing of New Medicines (Business & Management) at University College London, you need to submit a High School Transcript and a Test Score Report.

For the BS in Bioprocessing of New Medicines (Business & Management) at University College London, the English proficiency requirements are an IELTS score of 6.5 or higher, a PTE score of 75 or higher, or a TOEFL score of 92 or higher.

Graduates of the BS in Bioprocessing of New Medicines (Business & Management) at University College London can pursue careers in pharmaceutical companies, biotechnology firms, and regulatory agencies, focusing on the development and management of new medicines.

The BS in Bioprocessing of New Medicines (Business & Management) at University College London typically takes three to four years to complete, depending on the student's pace and course load.

University College London offers various scholarships for students enrolled in the BS in Bioprocessing of New Medicines (Business & Management). Prospective students are encouraged to check the university's scholarship page for eligibility and application details.

The BS in Bioprocessing of New Medicines (Business & Management) at University College London focuses on the intersection of bioprocessing and business management, equipping students with the skills needed to manage the development and commercialization of new medicines.